Steffen Daniel Kriechbaum

Dr. Steffen Daniel Kriechbaum


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
CLChristoph Lipps
Christoph Lipps
PNPhilipp Alexander Northe
Philipp Alexander Northe
RFRicardo Figueiredo
Ricardo Figueiredo
MRManfred Rohde
Manfred Rohde
ABAlexandra Brahmer
Alexandra Brahmer
CTChristian Troidl
Christian Troidl
Extracellular vesicles are released by numerous cell types of the human body under physiological but also under pathophysiological conditions. They are important for cell–cell communication and carry specific signatures of peptides and RNAs. In this study, we aimed to determine whether extracellular vesicles isolated from patients with pulmonary hypertension show a disease specific signature of small non-coding RNAs and thus have the potential to serve as diagnostic and prognostic biomarkers. Extracellular vesicles were isolated from the serum of 23 patients with chronic thromboembolic pulmonary hypertension (CTEPH) and 23 controls using two individual methods: a column-based method or by precipitation. Extracellular vesicle- associated RNAs were analyzed by next-generation sequencing applying molecular barcoding, and differentially expressed small non-coding RNAs were validated by quantitative real-time polymerase chain reaction (qRT-PCR). We identified 18 microRNAs and 21 P-element induced wimpy testis (PIWI)-interacting RNAs (piRNAs) or piRNA clusters that were differentially expressed in CTEPH patients compared with controls. Bioinformatic analysis predicted a contribution of these piRNAs to the progression of cardiac and vascular remodeling. Expression levels of DQ593039 correlated with clinically meaningful parameters such as mean pulmonary arterial pressure, pulmonary vascular resistance, right ventricular systolic pressure, and levels of N-terminal pro-brain natriuretic peptide. Thus, we identified the extracellular vesicle- derived piRNA, DQ593039, as a potential biomarker for pulmonary hypertension and right heart disease.

1 May 2018 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
SKSteffen Daniel Kriechbaum
Steffen Daniel Kriechbaum
CWChristoph B. Wiedenroth
Christoph B. Wiedenroth
JWJan Sebastian Wolter
Jan Sebastian Wolter
RHRegula Hütz
Regula Hütz
MHMoritz Haas
Moritz Haas
CLChristoph Liebetrau
Christoph Liebetrau

22 September 2020 in Biomarkers
Verified
Journal Article
Closed access
SKSteffen Daniel Kriechbaum
Steffen Daniel Kriechbaum
CWChristoph B. Wiedenroth
Christoph B. Wiedenroth
KPKarina Peters
Karina Peters
MBMarta A. Barde
Marta A. Barde
RARuth Ajnwojner
Ruth Ajnwojner
CLChristoph Liebetrau
Christoph Liebetrau
Purpose: This study examined sST2, GDF-15, and galectin-3 as indicators of disease severity and therapy response in chronic thromboembolic pulmonary hypertension (CTEPH). Methods: This study included 57 inoperable CTEPH patients who underwent balloon pulmonary angioplasty and 25 controls without cardiovascular disease. Biomarker levels were examined in relation to advanced hemodynamic impairment (tertile with worst right atrial pressure [RAP] and cardiac index), hemodynamic therapy response (normalized hemodynamics (meanPAP ≤25 mmHg, PVR ≤3 WU and RAP ≤6 mmHg) or a reduction of meanPAP ≥25%; PVR ≥35%, RAP ≥25%). Results: GDF-15 [820 (556-1315) pg/ml vs. 370 (314-516) pg/ml; p < 0.001] and sST2 [53.7 (45.3-74.1) ng/ml vs. 48.7 (35.5-57.0) ng/ml; p = 0.02] were higher in CTEPH patients than in controls. At baseline, a GDF-15 level ≥1443 pg/ml (AUC 0.88; OR 31.4) and a sST2 level ≥65 ng/ml (AUC 0.80; OR 10.9) were associated with advanced hemodynamic impairment. At follow-up GDF-15 ≤ 958 pg/ml (AUC =0.74, OR 18) identified patients with optimal hemodynamic therapy response and ≤760 pg/ml (AUC =0.79, OR 14). Conclusion: GDF-15 and sST2 levels are higher in CTEPH and identified patients with advanced hemodynamic impairment. Further, decreased GDF-15 levels at follow-up were associated with hemodynamic therapy response. The diagnostic strength was not superior to NT-proBNP.

15 April 2019 in Scandinavian Journal of Clinical and Laboratory Investigation
Verified
Journal Article
Closed access
SKSteffen Daniel Kriechbaum
Steffen Daniel Kriechbaum
CWChristoph B. Wiedenroth
Christoph B. Wiedenroth
MHMaura L. Hesse
Maura L. Hesse
RARuth Ajnwojner
Ruth Ajnwojner
TKTill Keller
Till Keller
CLChristoph Liebetrau
Christoph Liebetrau
Balloon pulmonary angioplasty (BPA), for chronic thromboembolic pulmonary hypertension, improves pulmonary and systemic hemodynamics. The kidney might benefit from this effect. However, staged BPA therapy comes along with repetitive administration of contrast agent. This study examined the overall effect of BPA therapy on renal function. This study included consecutive patients who underwent BPA treatment and completed a 6-month follow-up between March 2014 and March 2017. Biomarker-based evaluation of renal function was performed at baseline, consecutively prior to and after each BPA and at 6-month follow-up. The 51 patients underwent an average of 5 (±2) BPA sessions. In this course, patients received 133 (±48; 21–300) mL of contrast agent per session and 691 (±24; 240–1410) mL during the whole sequence. Acute kidney injury occurred after 6 (2.3%) procedures. The creatinine [80.1 (IQR 67.8–96.8) µmol/L vs. 77.4 (IQR 66.9–91.5) µmol/L, p = .02] and urea level [13.7 (IQR10.7–16.6) mmol/L vs. 12.5 (IQR 10.0–15.5) mmol/L, p = .02] decreased from baseline to the 6-month follow-up. The estimated glomerular filtration rate (eGFR) [79 (IQR 59–94) mL/min/m2 vs. 79.6 (IQR 67.1–95.0) mL/min/m2, p = .11] did not change. The Chronic kidney disease (CKD) stages at baseline were: G1:15; G2:23; G3a:10; G3b:2; G4:1; G5:0. Among patients with a CKD-stage ≥2, analysis revealed an increase of eGFR, decrease of creatinine and urea from baseline to 6-month follow-up. Among those patients, the baseline-CKD-stage improved in 14 (41.2%) patients. BPA therapy improves pulmonary and systemic hemodynamics, with positive effects on renal function. Repetitive administration of contrast agent seems not to be harmful regarding renal function.

25 September 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SKSteffen Daniel Kriechbaum
Steffen Daniel Kriechbaum
CWChristoph B Wiedenroth
Christoph B Wiedenroth
TKTill Keller
Till Keller
JWJan Sebastian Wolter
Jan Sebastian Wolter
RARuth Ajnwojner
Ruth Ajnwojner
CLChristoph Liebetrau
Christoph Liebetrau
Balloon pulmonary angioplasty (BPA) is an interventional treatment modality for inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Therapy monitoring, based on non-invasive biomarkers, is a clinical challenge. This post-hoc study aimed to assess dynamics of high-sensitivity cardiac troponin T (hs-cTnT) as a marker for myocardial damage and its relation to N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels as a marker for cardiac wall stress. This study included 51 consecutive patients who underwent BPA treatment and completed a 6-month follow-up (6-MFU) between 3/2014 and 3/2017. Biomarker measurement was performed consecutively prior to each BPA and at 6-MFU. In total, the 51 patients underwent an average of 5 BPA procedures. The 6-month survival rate was 96.1%. The baseline (BL) meanPAP (39.5±12.1mmHg) and PVR (515.8±219.2dyn×sec×cm-5) decreased significantly within the 6-MFU (meanPAP: 32.6±12.6mmHg, P<0.001; PVR: 396.9±182.6dyn×sec×cm-5, P<0.001). At BL, the median hs-cTnT level was 11 (IQR 6–16) ng/L and the median NT-proBNP level was 820 (IQR 153–1872) ng/L. The levels of both biomarkers decreased steadily after every BPA, showing the first significant difference after the first procedure. Within the 6-MFU, hs-cTnT levels (7 [IQR 5–12] ng/L; P<0.001) and NT-proBNP levels (159 [IQR 84–464] ng/l; P<0.001) continued to decrease. The hs-cTnT levels correlated with the PVR (rrs = 0.42; p = 0.005), the meanPAP (rrs = 0.32; p = 0.029) and the NT-proBNP (rrs = 0.51; p<0.001) levels at BL. Non-invasive biomarker measurement provides valuable evidence for the decreasing impairment of myocardial function and structure during BPA therapy. Changes in hs-cTNT levels are suggestive for a reduction in ongoing myocardial damage.

16 December 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
ARAndreas Rolf
Andreas Rolf
TKTill Keller
Till Keller
JWJan Sebastian Wolter
Jan Sebastian Wolter
SKSteffen Daniel Kriechbaum
Steffen Daniel Kriechbaum
MWMaren Weferling
Maren Weferling
JTJulia Treiber
Julia Treiber
Cardiac magnetic resonance (CMR) is currently the gold standard for evaluating right ventricular (RV) function, which is critical in patients with pulmonary hypertension. CMR feature-tracking (FT) strain analysis has emerged as a technique to detect subtle changes. However, the dependence of RV strain on load is still a matter of debate. The aim of this study was to measure the afterload dependence of RV strain and to correlate it with surrogate markers of contractility in a cohort of patients with chronic thromboembolic pulmonary hypertension (CTEPH) under two different loading conditions before and after pulmonary endarterectomy (PEA). Between 2009 and 2022, 496 patients with 601 CMR examinations were retrospectively identified from our CTEPH cohort, and the results of 194 examinations with right heart catheterization within 24 h were available. The CMR FT strain (longitudinal (GLS) and circumferential (GCS)) was computed on steady-state free precession (SSFP) cine CMR sequences. The effective pulmonary arterial elastance (Ea) and RV chamber elastance (Ees) were approximated by dividing mean pulmonary arterial pressure by the indexed stroke volume or end-systolic volume, respectively. GLS and GCS correlated significantly with Ea and Ees/Ea in the overall cohort and individually before and after PEA. There was no general correlation with Ees; however, under high afterload, before PEA, Ees correlated significantly. The results show that RV GLS and GCS are highly afterload-dependent and reflect ventriculoarterial coupling. Ees was significantly correlated with strain only under high loading conditions, which probably reflects contractile adaptation to pulsatile load rather than contractility in general.